Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy

Our aim is to determine the number of leukocytes, T lymphocytes and B lymphocytes and the expression of activation markers CD200 and CD23 on B lymphocytes in atopic dermatitis (AD) patients (treated and not treated with dupilumab) during the pollen season. We examined 29 patients not treated with du...

Full description

Bibliographic Details
Main Authors: Jarmila Čelakovská, Eva Čermáková, Petra Boudková, Ctirad Andýs, Jan Krejsek
Format: Article
Language:English
Published: Taylor & Francis Group 2024-08-01
Series:Immunological Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/25785826.2024.2387882